Viewing Study NCT02479620


Ignite Creation Date: 2025-12-25 @ 4:26 AM
Ignite Modification Date: 2026-03-04 @ 10:43 PM
Study NCT ID: NCT02479620
Status: UNKNOWN
Last Update Posted: 2020-02-19
First Post: 2015-06-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Lower-Limb Adventitial Infusion of DexaMethasone Via Bullfrog to Reduce Occurrence of Restenosis After Atherectomy (ATX)-Based Revascularization
Sponsor: Mercator MedSystems, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module